Robert Fürst
Impact in
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
- Ginger and Zingiberaceae research
Papers in
-
- Angiogenesis and VEGF in Cancer 7
- Ubiquitin and proteasome pathways 5
- Chemical Synthesis and Analysis 5
- Epidemiology 18
- HIV, Drug Use, Sexual Risk 10
- Substance Abuse Treatment and Outcomes 7
- Co-authors
- Angelika M. Vollmar (26 shared papers)Ilse Zündorf (3 shared papers)Stefan Zahler (29 shared papers)Alexandra K. Kiemer (5 shared papers)Angelo A. Izzo (1 shared paper)Alvaro Viljoen (1 shared paper)Oliver Kayser (1 shared paper)Giovanni Appendino (1 shared paper)
- Journals
- Planta Medica (6 papers)The FASEB Journal (5 papers)Biomedicine & Pharmacotherapy (5 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Angiogenesis (4 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Robert Fürst
116 papers receiving 3.8k citations
Robert Fürst's Hit Papers
Peers
Comparison fields: 5 of 165
- Pharmacology 344
- Complementary and alternative medicine 241
- Pharmacology 379
- Cancer Research 280
- Molecular Biology 1.3k
Countries citing papers authored by Robert Fürst
This map shows the geographic impact of Robert Fürst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Fürst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Fürst more than expected).
Fields of papers citing papers by Robert Fürst
This network shows the impact of papers produced by Robert Fürst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Fürst. The network helps show where Robert Fürst may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Fürst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Best practice in research – Overcoming common challenges in phytopharmacological research Hit paper breakdown → | 2019 | 402 |
| 2 | 1994 | 273 | |
| 3 | 2014 | 221 | |
| 4 | 2002 | 154 | |
| 5 | 2021 | 119 | |
| 6 | 2012 | 98 | |
| 7 | 2004 | 90 | |
| 8 | 2010 | 87 | |
| 9 | 2016 | 87 | |
| 10 | 1999 | 87 | |
| 11 | 2006 | 82 | |
| 12 | 2016 | 80 | |
| 13 | 2016 | 80 | |
| 14 | 1997 | 72 | |
| 15 | 2007 | 70 | |
| 16 | 2002 | 67 | |
| 17 | 1998 | 62 | |
| 18 | 2010 | 55 | |
| 19 | 2018 | 51 | |
| 20 | 2022 | 50 |
About Robert Fürst
Robert Fürst is a scholar working on Molecular Biology, Epidemiology, Organic Chemistry, Pharmacology and Oncology, having authored 120 papers that have together received 4.0k indexed citations. Recurring topics across this work include HIV, Drug Use, Sexual Risk (10 papers), Angiogenesis and VEGF in Cancer (7 papers), Substance Abuse Treatment and Outcomes (7 papers), Chemical synthesis and alkaloids (7 papers), Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (5 papers), Microbial Natural Products and Biosynthesis (5 papers) and Chemical Synthesis and Analysis (5 papers). The work is most often cited by research in Pharmacology (344 citations), Complementary and alternative medicine (241 citations), Pharmacology (379 citations), Cancer Research (280 citations) and Molecular Biology (1.3k citations). Robert Fürst has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Angelika M. Vollmar, Ilse Zündorf, Stefan Zahler, Alexandra K. Kiemer, Angelo A. Izzo, Alvaro Viljoen, Oliver Kayser, Giovanni Appendino, Thomas Efferth and John M. Pezzuto. Their work appears in journals such as Planta Medica, The FASEB Journal, Biomedicine & Pharmacotherapy, Arteriosclerosis Thrombosis and Vascular Biology and Angiogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.